James Wall

James Wall is an experienced professional in the fields of oncology and pharmacy practice, currently serving as Program Leader for Tumor Agnostic Rare Cancers and Global Studies Leader in Oncology/Hematology at Genentech since January 2016. In addition to roles at Genentech, James Wall is a Clinical Professor and has held various academic positions at the Thomas J. Long School of Pharmacy and Health Sciences at the University of the Pacific since December 2016. As Chief Executive Officer of Wall Pharmaceutical, James Wall has led the organization since December 2015. Previous experience includes pharmacy operations roles at AIDS Healthcare Foundation and Burn’s Drug. James Wall holds a Doctor of Pharmacy from the University of the Pacific, a Post-doctorate Fellowship in Oncology from Rutgers University, an MBA in International Business from Louisiana State University, and a Bachelor’s Degree in Applied Sciences from the University of the Pacific.